Viewing nowCombinationRotacan Tablets 10/16 Milligrams
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Green Cross Corp.

MFDS item code 201702405 · Approved 2017.05.16 · Insurance code 643605410
Treatment of hypertension, heart failure, and dyslipidemia; slowing the progression of atherosclerosis and reducing cardiovascular risk
This medication is used for patients who need to take both Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is used for patients with essential hypertension and heart failure patients with impaired left ventricular function who require additional therapy or are intolerant to ACE inhibitors. Rosuvastatin is used for dyslipidemia that cannot be controlled by diet and exercise, including hypercholesterolemia, heterozygous familial hypercholesterolemia, and combined hyperlipidemia. It also serves as an adjunct to diet for patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. It helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in patients at high risk for cardiovascular disease. Therefore, this medication is used to control blood pressure and cholesterol levels and improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil/rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with particular caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue the diet throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate according to LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or longer, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
The safety and efficacy in adolescents and children 18 years of age or younger have not been established. The safety and efficacy in adolescents and children 18 years of age or younger have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so discontinue use immediately upon confirmation of pregnancy. Patients who are allergic to this medication or have liver disease, kidney impairment, myopathy, hereditary angioedema, etc. should not take it. Women of childbearing potential should use appropriate contraception, and it is safer not to take this medication during pregnancy. Elderly patients, patients with hyperkalemia, and those with impaired liver or kidney function should take this medication with caution. If symptoms such as muscle pain or weakness occur, consult a physician immediately and if necessary, blood tests should be performed to check for muscle damage. This medication may affect liver function, so it is recommended to undergo liver function tests before and during treatment. There may be interactions with other medications, so if currently taking any other medications, it is crucial to inform your healthcare provider or pharmacist. This medication is not recommended during lactation; if breastfeeding, it is preferable to avoid taking it or to stop breastfeeding. Safety and efficacy have not been established for pediatric use. In cases of overdose, symptoms such as hypotension and dizziness may occur, necessitating an immediate visit to a healthcare facility. There is no specific antidote. Caution is needed when driving or operating machinery as dizziness may occur during treatment. Keep this medication out of the reach of children and do not transfer it to another container from the original.
Headache, nasopharyngitis, local infections, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, headache, itching, nausea, dizziness, orthostatic dizziness, papule, periodontitis, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, chest discomfort, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, angioedema, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, memory impairment, forgetfulness, amnesia, memory disorders, confusion, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disorders, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, dysgeusia, erectile dysfunction, dizziness, orthostatic dizziness, weakness, fever, sensory disturbance, dyspepsia, gastroenteritis, tachycardia, palpitations, myalgia, epistaxis, anxiety, depression, somnolence, dyspnea, rash, increased sweating, hematuria, intestinal vascular edema, diarrhea, increased liver enzyme levels, hepatitis, jaundice, rash, urticaria, angioedema, myalgia, weakness, elevated creatine kinase, rhabdomyolysis, arthralgia, myalgia, low back pain, renal function impairment, acute kidney injury, interstitial pneumonia, shock, syncope, loss of consciousness, hypotension, increased blood pressure, cerebral infarction, spondylitic myelopathy, musculoskeletal discomfort, pneumonia, femur fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, worsening hypertension, unstable blood pressure, vertigo, orthostatic vertigo, adrenal insufficiency
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. This helps maintain the medication's effectiveness for a long time.
Yellow round film-coated tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Green Cross Corp.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.